how do you maintain weight loss after semaglutide Woman shares journey of and gain using Semaglutide (Ozempic® & Wegovy®) Before

Clinicaltrials.gov, 2025)

[1] Your underlying health conditions that led to Wegovy being prescribed may themselves affect donation eligibility, regardless of the medication

Mounjaro (tirzepatide) produces greater average weight loss than Wegovy (22.5% vs

In this study, we studied patients with overweight or obesity initiating either semaglutide or tirzepatide between May 2022 and September 2023

Contraindications: Despite the reassuring human data, as a precaution, these medications are not recommended for anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)